Hisamitsu, known for its Salonpas pain-relief patches, joins a growing list of Japanese companies exiting the public market.

Hisamitsu Pharmaceutical Co. is considering a takeover bid to privatize the Japanese maker of pain-relief patches in a deal ...

The Japanese government has been promoting cheaper generic medicines and pushing drugmakers to cut prices as its population ...

A growing list of companies are exiting the public market to shield themselves from growing regulatory and investor pressure ...

Japan's Hisamitsu Pharmaceutical Co. has said it will go private through a management buyout scheme worth about 390 billion yen. According to Hisamitsu's announcement Tuesday, an asset management ...

Once used mainly for distraction, VR is now being studied as a way to retrain the brain’s pain pathways—especially for people ...

Hisamitsu Pharmaceutical Co. is set to climb to its daily trading limit for a second day after the Japanese maker of ...

Use heat: To soothe painful spots from the inside, sip warm pepper­mint tea, which has been shown to help GI symptoms. To ...

The proposed offer of ¥6,082 per share represents a roughly 35% premium to Hisamitsu’s unaffected closing price on Monday.

Japan’s response to China’s latest export controls is likely to be cautious, reflecting limited options for retaliation.

At Stanford, a treatment that aims magnetic pulses at the brain is showing results for people with treatment-resistant depression. It’s called SAINT, and here’s how it works.

For people living with lupus, pain can be one of the most persistent and difficult symptoms to manage. But the good news is that a combination of medical treatments, lifestyle changes and ...